TFC7 Antibody

What is TFC7 and why is it important in research?

TFC7 (Transcription factor tau 55kDa subunit) is a subunit of the transcription factor TFIIIC complex found in Saccharomyces cerevisiae (Baker's yeast). It plays a crucial role in RNA polymerase III-mediated transcription, making it an important target for studies on eukaryotic transcriptional regulation. The TFC7 antibody provides researchers with a tool to detect, quantify, and study this protein in various experimental contexts .

The significance of TFC7 lies in its involvement in the transcription of various RNAs, including tRNAs and 5S rRNA. Understanding the function and regulation of TFC7 contributes to our knowledge of fundamental cellular processes that are conserved across eukaryotes.

What are the molecular characteristics of commercial TFC7 antibodies?

Commercial TFC7 antibodies are typically polyclonal antibodies raised in rabbits against recombinant Saccharomyces cerevisiae TFC7 protein. Their molecular characteristics include:

These antibodies are designed for research applications such as ELISA and Western blot analysis, with validation specifically for detection of the recombinant immunogen protein .

How should I optimize Western blot protocols for TFC7 antibody?

Optimizing Western blot protocols for TFC7 antibody requires careful consideration of several parameters:

Sample Preparation:

• Extract proteins from yeast cells in mid-log phase for optimal TFC7 expression

• Use a lysis buffer containing protease inhibitors to prevent degradation (e.g., 50mM Tris-HCl pH 7.5, 150mM NaCl, 1% NP-40, protease inhibitor cocktail)

• Sonicate samples briefly to shear DNA and reduce sample viscosity

Western Blot Protocol Optimization:

• Load 20-40μg of total protein per lane

• Use 8-10% SDS-PAGE gels for optimal resolution of the ~55kDa TFC7 protein

• Transfer to PVDF membranes (rather than nitrocellulose) for improved signal

• Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

• Dilute primary antibody at 1:500 to 1:2000 in blocking buffer

• Incubate overnight at 4°C with gentle agitation

• Wash thoroughly with TBST (4 times, 5 minutes each)

• Use HRP-conjugated anti-rabbit secondary antibody (1:5000 dilution)

• Develop using enhanced chemiluminescence

Troubleshooting Low Signal:

• Increase antibody concentration

• Extend incubation time

• Use signal enhancement systems

• Ensure your sample contains sufficient TFC7 protein

Expected results: A specific band should be visible at approximately 55kDa, corresponding to the TFC7 protein .

What are the recommended ELISA conditions for TFC7 antibody?

ELISA optimization for TFC7 antibody requires attention to several key parameters:

Direct ELISA Protocol:

• Coat plates with recombinant TFC7 protein (1-10μg/ml in carbonate buffer pH 9.6)

• Incubate overnight at 4°C

• Wash with PBS-T (PBS + 0.05% Tween-20)

• Block with 2-5% BSA in PBS for 1-2 hours at room temperature

• Add TFC7 antibody in serial dilutions (starting from 1:100 to 1:5000)

• Incubate for 1-2 hours at room temperature

• Wash thoroughly with PBS-T

• Add HRP-conjugated anti-rabbit secondary antibody (1:5000 dilution)

• Develop with TMB substrate and measure absorbance at 450nm

For Sandwich ELISA:

• Use a capture antibody against another epitope of TFC7

• Apply sample containing TFC7 protein

• Use TFC7 polyclonal antibody as detection antibody

Optimization Parameters:

• Antibody dilution (typically 1:500 to 1:2000)

• Incubation temperature (4°C or room temperature)

• Incubation time (1-2 hours or overnight)

• Blocking agent (BSA, milk, or commercial blocking buffers)

The antibody demonstrates robust performance in ELISA with minimal background when properly optimized .

How can I validate the specificity of TFC7 antibody in my experiments?

Validating antibody specificity is crucial for reliable research results. For TFC7 antibody, employ multiple validation strategies:

Positive Controls:

• Use recombinant TFC7 protein as a positive control

• Include wild-type S. cerevisiae lysate with known TFC7 expression

Negative Controls:

• Use pre-immune serum provided with the antibody

• Include TFC7 knockout/knockdown samples if available

• Test reactivity against non-target species or tissues

Validation Techniques:

• Western Blot validation: Observe a single band at the expected molecular weight (~55kDa)

• Immunoprecipitation followed by Mass Spectrometry: Confirm the identity of precipitated proteins

• Peptide Competition Assay: Pre-incubate antibody with excess immunizing peptide, which should abolish specific binding

• Multiple Antibody Approach: Compare results with another TFC7 antibody targeting a different epitope

Documentation of Validation:

• Record all validation steps, including controls and observed band patterns

• Note batch-to-batch variations and record lot numbers

• Document species-specificity limitations

Proper validation ensures experimental rigor and reproducibility, critical for publication-quality research .

What storage and handling practices maximize TFC7 antibody performance?

Proper handling and storage significantly impact antibody performance. For TFC7 antibody:

Storage Recommendations:

• Store at -20°C or -80°C for long-term preservation

• Avoid repeated freeze-thaw cycles by preparing working aliquots

• Add glycerol (final concentration 30-50%) to prevent freeze-thaw damage

• Keep antibody on ice when in use

Handling Best Practices:

• Centrifuge briefly before opening vial to collect liquid at the bottom

• Use sterile techniques to prevent contamination

• Avoid vortexing; mix by gentle inversion or pipetting

• Return to appropriate storage conditions promptly after use

Stability Considerations:

• Antibody stability decreases after 12 months, even with proper storage

• Document date of receipt and first use

• Perform validation tests on older antibody preparations before crucial experiments

• Monitor for signs of precipitation or aggregation

Transportation:

• Transport on dry ice for shipments

• Maintain cold chain during laboratory transfers

Proper storage and handling significantly extend antibody shelf-life and maintain consistent experimental results .

How can I use TFC7 antibody in chromatin immunoprecipitation (ChIP) experiments?

While the TFC7 antibody is not explicitly validated for ChIP in the search results, researchers can adapt it for this purpose with appropriate optimization:

ChIP Protocol Adaptation:

• Crosslinking: Treat yeast cells with 1% formaldehyde for 10-15 minutes

• Chromatin Preparation:

  • Lyse cells in ChIP lysis buffer (50mM HEPES-KOH pH 7.5, 140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate)

  • Sonicate to generate 200-500bp DNA fragments

• Immunoprecipitation:

  • Pre-clear chromatin with protein A beads

  • Incubate cleared chromatin with 5-10μg TFC7 antibody overnight at 4°C

  • Add protein A beads and incubate for 2-3 hours

• Washing and Elution:

  • Wash extensively with increasing stringency buffers

  • Elute DNA-protein complexes with elution buffer (1% SDS, 100mM NaHCO₃)

• Reverse Crosslinking and DNA Purification:

  • Heat at 65°C overnight

  • Treat with proteinase K

  • Purify DNA using spin columns

Expected TFC7 Binding Sites:

• tRNA genes

• 5S rRNA genes

• Other RNA polymerase III transcribed genes

Controls for ChIP Experiments:

• Input chromatin (pre-immunoprecipitation sample)

• IgG control (non-specific rabbit IgG)

• Positive control (antibody against known Pol III-associated factor)

ChIP-qPCR Primer Design:
Design primers for known TFIIIC binding sites as positive controls and non-Pol III transcribed regions as negative controls.

Can I use TFC7 antibody for studying protein-protein interactions involving transcription complexes?

TFC7 antibody can be valuable for analyzing protein-protein interactions within transcription complexes:

Co-Immunoprecipitation (Co-IP) Protocol:

• Prepare yeast lysate under native conditions (avoiding harsh detergents)

• Pre-clear lysate with protein A beads

• Incubate with 2-5μg TFC7 antibody overnight at 4°C

• Add protein A beads and incubate for 2 hours

• Wash thoroughly with IP buffer

• Elute bound proteins with SDS sample buffer

• Analyze by SDS-PAGE followed by:

  • Western blot for known interacting partners

  • Silver staining followed by mass spectrometry for unbiased discovery

Proximity Ligation Assay (PLA) Applications:

• Fix yeast cells with 4% paraformaldehyde

• Permeabilize with suitable agent (e.g., 0.1% Triton X-100)

• Block with 5% BSA

• Incubate with TFC7 antibody and antibody against potential interacting partner

• Follow PLA protocol with appropriate secondary antibodies

• Analyze under fluorescence microscope

Expected Interaction Partners:

• Other TFIIIC components

• RNA polymerase III subunits

• Chromatin remodeling factors

• Relevant transcription regulators

This approach can reveal novel insights into transcription complex assembly and regulation in yeast, with potential implications for understanding equivalent mammalian systems.

What methodologies can I employ to study TFC7 post-translational modifications using this antibody?

Post-translational modifications (PTMs) of transcription factors often regulate their activity. To study TFC7 PTMs:

Phosphorylation Analysis:

• Phosphatase Treatment:

  • Split yeast lysate into two samples

  • Treat one with lambda phosphatase

  • Compare migration patterns by Western blot with TFC7 antibody

• Phos-tag SDS-PAGE:

  • Incorporate Phos-tag reagent in acrylamide gels

  • Run normal and phosphatase-treated samples

  • Detect with TFC7 antibody

• IP-MS Analysis:

  • Immunoprecipitate TFC7 using the antibody

  • Analyze by mass spectrometry to identify phosphorylation sites

Other PTM Analyses:

• Ubiquitination:

  • Co-IP with TFC7 antibody

  • Probe Western blots with anti-ubiquitin antibody

• SUMOylation:

  • IP under denaturing conditions

  • Probe with anti-SUMO antibodies

• Acetylation:

  • IP with TFC7 antibody

  • Probe with anti-acetyl-lysine antibody

Functional Analysis of PTMs:

• Correlate PTM patterns with cell cycle phases

• Examine changes in PTMs under stress conditions

• Analyze PTM patterns in mutant strains with defects in specific modification pathways

Understanding TFC7 PTMs can provide insights into the regulation of RNA polymerase III transcription under different cellular conditions.

How does TFC7 antibody compare to other transcription factor antibodies in multiparameter studies?

When conducting multiparameter studies involving multiple transcription factors:

Compatibility in Multiplex Immunoassays:

• Co-immunostaining:

  • Test for cross-reactivity between antibodies

  • Optimize antibody dilutions independently before combining

  • Use secondary antibodies with minimal cross-reactivity

• Sequential ChIP (Re-ChIP):

  • First IP with TFC7 antibody

  • Elute under mild conditions

  • Second IP with antibody against another transcription factor

  • Compare enrichment patterns with single ChIP results

Comparative Detection Sensitivity:

Applications in Systems Biology:

• Network analysis of transcription regulation

• Integration with RNA-seq data

• Correlation with chromatin accessibility maps

• Combinatorial occupancy studies with other transcription factors

These comparative approaches can reveal the coordination between RNA polymerase III transcription (via TFC7) and other transcriptional systems in the cell.

What experimental design considerations are critical when studying TFC7 in different yeast strains or growth conditions?

When investigating TFC7 across different experimental conditions:

Strain Considerations:

• Genetic Background:

  • Document complete genotype of strains

  • Consider potential influence of background mutations

  • Verify TFC7 sequence in non-standard strains

• Expression Level Variations:

  • Use quantitative Western blots to normalize TFC7 levels across strains

  • Consider using epitope-tagged TFC7 for consistent detection

Growth Condition Variables:

• Media Composition:

  • Nutrient-rich vs. minimal media affects TFC7 activity

  • Carbon source influences RNA Pol III transcription

• Growth Phase:

  • Exponential vs. stationary phase exhibits different TFC7 binding patterns

  • Synchronize cultures for cell-cycle studies

Environmental Stress Response:

• Stress Conditions:

  • Heat shock (37-42°C)

  • Nutrient limitation

  • Oxidative stress (H₂O₂ treatment)

• Time Course Analysis:

  • Sample at multiple time points after stress induction

  • Monitor TFC7 localization, modification, and activity changes

Experimental Controls:

• Include wild-type controls in each experimental batch

• Process all samples simultaneously when possible

• Use spike-in controls for quantitative comparisons

This systematic approach ensures reliable detection of condition-specific changes in TFC7 behavior that may have functional significance.

How might TFC7 antibody contribute to understanding evolutionary conservation of transcription machinery?

The TFC7 antibody can enable comparative studies across species:

Cross-Species Applications:

• Testing Cross-Reactivity:

  • Evaluate antibody reactivity in closely related yeast species

  • Test against predicted homologs in other fungi

• Homolog Identification:

  • Use TFC7 antibody to isolate complexes from related species

  • Identify components by mass spectrometry

  • Compare complex composition across evolutionary distance

Functional Conservation Analysis:

• Binding Site Conservation:

  • Compare TFC7 binding sites in different yeast species

  • Correlate with conservation of promoter elements

• Complex Assembly:

  • Analyze interaction partners across species

  • Identify conserved vs. species-specific interactions

Evolutionary Implications:

• Track changes in RNA Pol III machinery across fungal evolution

• Identify core conserved functions vs. species-specific adaptations

• Connect to broader principles of transcriptional machinery evolution

This research direction can provide insights into the fundamental aspects of eukaryotic transcription that have been maintained throughout evolution.

What methodological approaches can enhance the utility of TFC7 antibody in single-cell studies?

While challenging with yeast cells, adaptations for single-cell analysis include:

Single-Cell Immunostaining:

• Protocol Optimization:

  • Spheroplast preparation with digestive enzymes

  • Careful fixation to preserve nuclear structure

  • Enhanced permeabilization for antibody accessibility

  • Signal amplification systems for detection

• Quantitative Image Analysis:

  • Measure nuclear vs. cytoplasmic distribution

  • Quantify signal intensity variations

  • Correlate with cell cycle stage

Integration with Other Single-Cell Techniques:

• With scRNA-seq:

  • Use TFC7 antibody in CITE-seq-like approaches

  • Correlate protein levels with transcriptional output

• With Single-Cell Epigenomics:

  • Compare TFC7 binding with chromatin accessibility

  • Integrate with single-cell ChIP data when available

Technical Innovations:

• Microfluidic approaches for consistent cell handling

• Automated image analysis for high-throughput processing

• Adaptation of CUT&Tag for single-cell applications

These approaches can reveal cell-to-cell variability in TFC7 localization and function, potentially uncovering new regulatory principles in transcription.